Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease
2009

The Role of Paraoxonase-1 in Liver Disease

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): Marsillach Judit, Camps Jordi, Ferré Natàlia, Beltran Raul, Rull Anna, Mackness Bharti, Mackness Michael, Joven Jorge

Primary Institution: Centre de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d'Investigacions Sanitàries Pere Virgili, Universitat Rovira i Virgili

Hypothesis

What is the relationship between hepatic PON1 and MCP-1 expression in rats with liver disease?

Conclusion

The study suggests that PON1 has a protective role against inflammation and fibrosis in liver disease.

Supporting Evidence

  • PON1 levels increased in the liver after CCl4 exposure.
  • MCP-1 levels were significantly higher in CCl4-administered rats.
  • There were significant relationships between hepatic PON1 and MCP-1 concentrations.

Takeaway

PON1 helps protect the liver from damage and inflammation, and when it's low, the liver can get worse.

Methodology

Rats were given CCl4 to induce liver damage, and levels of PON1 and MCP-1 were measured over time.

Participant Demographics

Male Wistar rats weighing approximately 207 g.

Statistical Information

P-Value

0.005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-230X-9-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication